CST BLOG

The official blog of Cell Signaling Technology, where we discuss what to expect from your time at the bench, share tips, tricks, and information.

CST Blog

Read More →

Research Round-Up: CST Anti-CAR Linker Antibodies in the Literature

As chimeric antigen receptor (CAR) cell therapies for the treatment of solid tumors, hematologic mal...
Alexandra Foley Jun 2, 2026

Hallmarks of Cancer: Tumor-Promoting Inflammation

Inflammation can play different roles in the context of cancer. Short-lived inflammatory signaling c...
Rob MacDonald, PhD Mar 25, 2026

Unlocking Protein-Level Insights in CAR-T Single Cell Analysis

Single cell RNA sequencing (scRNA-seq) has been a powerful tool to uncover heterogeneity in T cell p...
Majd Ariss, PhD Feb 4, 2026

Three Reasons Flow Cytometry Controls Give You CAR Confidence

Chimeric Antigen Receptor (CAR) cell therapies continue to advance, but the high cost and lengthy ti...
Andrea Tu, PhD Jul 23, 2025

Immunology: What are myeloid cells and how are they identified?

During hematopoiesis, myeloid cells develop from a common myeloid progenitor (CMP) found in the bone...
Rob MacDonald, PhD May 22, 2025

Immunology: What are lymphoid cells and how are they identified?

In humans, hematopoietic stem cells (HSCs) continuously replenish all types of blood cells via a ser...
Amrik Singh, PhD May 21, 2025

Spatial Insights for CAR-Engineered Cells in Solid Tumors: Antibody-Based CAR Detection Method

Cell Signaling Technology provides products and services are for research use only and not for use i...
Amrik Singh, PhD Apr 16, 2025

Menin-KMT2A Inhibitors: A Promising Approach to Acute Myeloid Leukemia (AML) Treatment

Accounting for about 80% of adult acute leukemias, acute myeloid leukemia (AML) is an aggressive for...
Homa Rahnamoun, PhD Oct 16, 2024

Interrogating Immunometabolism in the TME Using a Metabolic Checkpoint

Previously considered distinct disciplines, the fields of immunology and metabolism are converging i...
Jianxin Xie, PhD Apr 17, 2024

Simplify Immuno-Oncology Research with One-Step, Bead-Free T Cell Activation & Expansion

The success of immuno-oncology therapeutics has opened the door to novel cancer elimination strategi...
Andrea Tu, PhD Sep 20, 2023

Cancer Immunotherapy Awareness Month: Fueling the Next Scientific Breakthrough

Did you know June is Cancer Immunotherapy Research Awareness Month? This year, we’ll celebrate 10 ye...
Andrea Tu, PhD Jun 21, 2023

AACR 2023 Recap: Immunotherapy, CAR-T Cell Therapy Research Dominate

Last month marked the annual American Association for Cancer Research (AACR 2023) meeting, which gat...
Alexandra Foley May 10, 2023

World Cancer Day: A Global Call to Action

Most people will either be directly or indirectly affected by a cancer diagnosis at some point in th...
Alexandra Foley Feb 6, 2023

CAR T Cell Detection: Anti-CAR Linker Antibodies for Whitlow/218 & G4S

CST® anti-CAR linker antibodies won The Innovation Award from CiteAb in 2023. Read on to learn why! ...
Amrik Singh, PhD Nov 8, 2022

Therapeutic Approaches for the Treatment of Multiple Myeloma

Multiple myeloma is a cancer of plasma cells that is treatable, but not curable. In this blog, we re...
Andrea Tu, PhD Jul 2, 2022

Targeting TIGIT for Cancer Immunotherapy & T Cell Exhaustion

The evolution of solid tumor cancer treatment has historically centered on a tripartite approach tha...
Tamar Aprahamian, PhD Feb 17, 2021

      Categories

      25-JRY-19751_TrialSize_Blog Listing Ad

      CST Newsletter

      Popular Posts

      Recent Posts
      CST blog Cellular Landscape Footer